Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
1,049,389
-
Shares change
-
-121,764
-
Total reported value, excl. options
-
$6,599,330
-
Value change
-
-$770,810
-
Number of buys
-
12
-
Number of sells
-
-22
-
Price
-
$6.29
Significant Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q3 2024
42 filings reported holding NVCT - Nuvectis Pharma, Inc. - COM as of Q3 2024.
Nuvectis Pharma, Inc. - COM (NVCT) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,049,389 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (301,138 shares), BALDWIN WEALTH PARTNERS LLC/MA (174,130 shares), GEODE CAPITAL MANAGEMENT, LLC (79,716 shares), MILLENNIUM MANAGEMENT LLC (68,499 shares), IRIDIAN ASSET MANAGEMENT LLC/CT (55,380 shares), GSA CAPITAL PARTNERS LLP (50,129 shares), BlackRock, Inc. (49,554 shares), FORBES J M & CO LLP (48,401 shares), MARSHALL WACE, LLP (42,814 shares), and TWO SIGMA INVESTMENTS, LP (26,785 shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.